Palabras clave
scarring alopecia
hair disorders
biologics
TNFα-inhibitors
hair disorders
biologics
TNFα-inhibitors
Cómo citar
Martin, R., & Rullán, J. M. (2015). Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab. Puerto Rico Health Sciences Journal, 34(2). Recuperado a partir de https://prhsj.rcm.upr.edu/index.php/prhsj/article/view/1136
Resumen
Dissecting cellulitis of the scalp (DCS ) is an uncommon inflammatory disease that often results in scarring alopecia. Numerous therapies have either proved ineffective or only temporarily effective in the management of this condition. Recent reports show adequate responses to tumor necrosis factor (TNF) inhibitors in cases of DCS. We report a case of severe recalcitrant DCS successfully treated with adalimumab.
Authors who publish with this journal agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).